Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex
Study sponsor: Tarsus Pharmaceuticals, Inc. · TARS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-06-15Estimated
Enrollment · participants36Estimated
Source updated2024-04-09Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.